Archive | COG RSS for this section

COVID-19 information for survivors of childhood, adolescent and young adult cancers is available from COG LTFU Guidelines website.

Our colleagues at UAB, Wendy Landier and Smita Bhatia, have organized a Health Link for our survivors that addresses issues about COVID-19.  English and Spanish versions are attached and can also be downloaded at .

Please share freely with your task force members, pediatric oncology clinicians at your institutions, and survivors and families.

Release of COG LTFU Guidelines, Version 5.0

Dear COG Member,

I am pleased to announce the release of Version 5.0 of the Children’s Oncology Group Long-Term Follow-Up Guidelines.  Since 2003, the COG LTFU Guidelines have been integral to directing the long-term follow-up care provided by COG institutions for survivors of childhood, adolescent, and young adults cancers.

There are significant changes to Version 5.0 of these guidelines, including simplification of the design and format, re-definition of the radiation fields, and elimination of most radiation dose cut-offs.  Details of the revisions are summarized in the guideline front-matter (see “New to Version 5.0”).

Over 150 of our members contributed to the current guideline revisions. These efforts were led by the Guideline Core Committee (Melissa Hudson, Wendy Landier, Louis S. Constine, and Smita Bhatia) within the Outcomes and Survivorship Committee under the leadership of Eric Chow, with the generous support of St. Baldrick’s Foundation.

The updated COG LTFU Guidelines Version 5.0, and associated materials for their clinical application, are now available at


Peter C. Adamson MD

Chair, Children’s Oncology Group

CYP-C is looking for research champions

Please watch our video, and we would love to see you at the Canadian Investigators meeting at COG in Atlanta this September.


Contact Randy Barber ( for more details.


COG Canadian Regulatory Affairs Meeting

The Canadian Regulatory Affairs meeting at the COG Spring Meeting in Atlanta, GA will be held from 7:00 – 9:00 AM, Thursday, April 16.

On the agenda: updates on regulatory compliance issues, new protocols, the monitoring program and the most recent Health Canada inspection.